Skip to main content

Internet Explorer 11 (IE11) is not supported. For the best experience please open using Chrome, Firefox, Safari or MS Edge

MHC logo CAPSULE
Medical Devices Pharma Digital Health Cosmetics Food Chemicals
Menu
  • Sectors
  • Medical Devices
  • Pharma
  • Digital Health
  • Cosmetics
  • Food
  • Chemicals
  • Practice Areas
  • Artificial Intelligence
  • Commercial
  • Competition
  • Construction
  • Corporate Governance
  • Cyber Security
  • Data Privacy
  • ESG
  • Healthcare Litigation
  • Intellectual Property
  • Product Liability
  • Real Estate
  • Regulatory
  • Tax
  • Transactional
  • Other
  • Latest
  • People
Search Capsule
Site Search

L a t e s t

  • All
  • News
  • Events
  • Insights
  • Podcasts
  • Videos
  • Clear ✕
  • Clear ✕

03/10/25

NIS2 Considerations for the Life Sciences Sector

Insights Pharma

01/10/25

Renegotiation of the IPHA Framework Agreement Update

Insights Pharma

23/09/25

Pricing & Reimbursement in Ireland

Insights Pharma

13/08/25

Non-Party Costs Orders

Insights Healthcare Litigation

10/07/25

Greenwashing: Update on the Green Claims Directive

Insights ESG

22/05/25

Consolidation in Supply Chains: Trends and Implications for Dispute Resolution

Insights Healthcare Litigation

25/04/25

Boohoo in Ireland: Could ESG Failures Spark Investor Claims?

Insights ESG

27/03/25

Recent AI Act Guidance: What You Need to Know

Insights Artificial Intelligence

27/03/25

Are You Certified for Angel Investor Relief?

Insights Tax

20/02/25

Avoiding Disputes in your Supply Chain

Insights Food

13/02/25

Are ‘No Poach’ Agreements Putting Your Business at Risk?

Insights Competition

05/02/25

Converting Offices to Life Sciences Spaces

Insights Pharma

05/02/25

Company Law Reforms Affecting the Life Sciences Sector

Insights Pharma

09/12/24

New Company Law Provisions in Focus

Insights Corporate Governance

06/12/24

Ireland’s New Participation Exemption

Insights Tax

28/11/24

Ireland's Tax Landscape in 2025

Insights Tax
Loading
MHC logo CAPSULE
  • Sectors
  • Medical Devices
  • Pharma
  • Digital Health
  • Cosmetics
  • Food
  • Chemicals
  • Other
  • Latest
  • People
  • Practice Areas
  • Artificial Intelligence
  • Commercial
  • Competition
  • Construction
  • Corporate Governance
  • Cyber Security
  • Data Privacy
  • ESG
  • Healthcare Litigation
  • Intellectual Property
  • Product Liability
  • Real Estate
  • Regulatory
  • Tax
  • Transactional
  • Accolades
  • Client Choice
  • Lexology Index
Privacy Policy | Cookie Policy | Disclaimer | Modern Slavery Statement | Accessibility | ©2026 Mason Hayes & Curran LLP